|
|
Early diagnostic value and clinical significance of procalcitonin in patients with chronic obstructive pulmonary disease complicated with heart failure complicated with pulmonary infection |
YAO Zhi-qiang HUANG Gui-qiong YUAN Wei-wei ZHANG Xu-mei |
The First Department of Cardiology,Hospital of Traditional Chinese Medicine in Huizhou City of Guangdong Province,Huizhou 516001,China |
|
|
Abstract ObjectiveTo investigate the value of procalcitonin in the early diagnosis and clinical significance of chronic obstructive pulmonary disease complicated with heart failure accompanied by pulmonary infection.MethodsChoose from January 2016 to May 2017 in our hospital accepts patients with 60 cases,complicated with heart failure with pulmonary infection in 20 cases,as the observation group,only 20 cases have heart failure as the reference group,20 healthy cases as control group.The procalcitonin level and the detection of pathogens in the three groups were observed.ResultsThe difference in calcitonin level between the three groups was statistically significant(P<0.05).Famian detected in pathogenic bacteria,chronic obstructive pulmonary disease complicated with heart failure in patients with lung infection there was a variety of pathogenic bacteria,gram negative bacteria were mainly;and the gram negative bacteria and gram positive bacteria group comparison,the procalcitonin levels also showed significant differences(P<0.05);at the same time in different levels in patients with chronic obstructive pulmonary disease,procalcitonin levels also had significant difference.ConclusionThere is a significant difference in procalcitonin levels in patients with chronic obstructive pulmonary disease complicated with heart failure accompanied by pulmonary infection,and clinical treatment can be carried out according to the level of procalcitonin.
|
|
|
|
|
Cite this article: |
YAO Zhi-qiang,HUANG Gui-qiong,YUAN Wei-wei, et al. Early diagnostic value and clinical significance of procalcitonin in patients with chronic obstructive pulmonary disease complicated with heart failure complicated with pulmonary infection[J]. 中国当代医药, 2017, 24(33): 85-87.
|
|
|
|
URL: |
http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I33/85 |
[1] |
夏爽,黄贤胜,李舒承,等.降钙素原测定在老年心力衰竭合并肺部感染中的诊断价值[J].临床心血管病杂志,2016,32(10):1013-1015.
|
[2] |
刘义冰.慢性阻塞性肺疾病急性加重期C-反应蛋白及降钙素原的临床诊断价值[J].中国现代医生,2017,55(7):16-18,32.
|
[3] |
周小林.白细胞分类计数及降钙素原在慢性阻塞性肺疾病伴感染中的相关性分析[J].中外医学研究,2016,14(34):46-47.
|
[4] |
吴华家,朱冬宁,鲍俊.血清降钙素原在慢阻肺急性加重期患者抗感染治疗中的指导作用[J/OL].安徽医学,2016,37(7):840-842.
|
[5] |
吴琪茵,许巧珍,胡妙芬.慢性阻塞性肺疾病患者中性粒细胞计数与感染的相关性分析[J].中国卫生标准管理,2016,7(7):36-37.
|
[6] |
谢桂容.血清PCT和hs-CRP检测在AECOPD患者中的临床价值[J].河北医学,2015,21(6):923-925.
|
[7] |
叶春幸,林华胜,卓宋明,等.慢性阻塞性肺疾病急性加重期患者血清降钙素原和C反应蛋白检测的临床意义[J].广东医学院学报,2015,33(2):163-166.
|
[8] |
尹燕,刘怡妍,侯刚,等.下呼吸道感染患者血浆和肽素和降钙素原水平变化及其临床意义研究[J].实用心脑肺血管病杂志,2015,23(4):32-36.
|
[9] |
成劲松.COPD患者急性加重期血清降钙素原水平的变化及其临床指导作用研究[J].中外医学研究,2015,13(1):46-47.
|
[10] |
雷振东,邱泽亮,雷李美,等.降钙素原水平对老年慢性阻塞性肺疾病急性加重期选用抗菌药物的指导价值[J].中国全科医学,2014,17(35):4245-4247.
|
[11] |
刘德义,马胜喜,刘雨婷.白细胞及降钙素原在慢性阻塞性肺疾病患者感染的相关性分析[J/OL].中华医院感染学杂志,2014,24(15):3879-3881.
|
[12] |
蓝丹,叶晓涛,廖长征,等.降钙素原和超敏C反应蛋白检测在慢性阻塞性肺疾病急性加重中的意义[J].国际检验医学杂志,2014,35(12):1573-1574.
|
[13] |
刘远新.降钙素原在慢性阻塞性肺疾病急性加重期诊治中的应用[J].中国当代医药,2013,20(14):75-76,78.
|
[14] |
刘玉玲,赵小慧,张克武.降钙素原与超敏C-反应蛋白在慢性阻塞性肺疾病急性加重期中的临床意义[J].中国煤炭工业医学杂志,2012,15(9):1384-1385.
|
[15] |
保勇,史梦,喻华,等.检测血清降钙素原对感染性疾病及脓毒症的诊断价值[J].实用医院临床杂志,2012,29(1):94-96.
|
|
|
|